Replimune prices $225M public offering of common stock and pre-funded warrants

Replimune Group, Inc.

Offering of 5.37M shares at $23.50/share and pre-funded warrants for 4.20M shares at $23.4999/warrant.
Underwriters' 30-day option for 1.44M additional shares exercised in full.
Net proceeds estimated at $242.6M after underwriting discounts and expenses.
Offering expected to close December 13, 2022, funded from shelf registration.
J.P. Morgan, SVB Securities, Piper Sandler, and BMO Capital Markets are joint book-runners.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.